"At the Middlesex Health Cancer Center, our expert team uses the most advanced technology to provide evidence-based and compassionate care for the whole person - body, mind, and spirit. Our collaboration with the Mayo Clinic brings the best cancer care closer to home and provides our patients with access to some of the top cancer specialists in the world."

During the past decade, Middlesex Hospital Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 12 clinical trials were completed, i.e. on average, 1200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Middlesex Hospital Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 6 trials, followed by "NSABP Foundation Inc" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Middlesex Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Middlesex Hospital Cancer Center" are "Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials), "Anal Cancer" (1 trials) and "Breast Adenocarcinoma" (1 trials). Many other conditions were trialed in "Middlesex Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Middlesex Hospital Cancer Center" are "Drug" (13 trials), "Other" (5 trials), "Biological" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (4 trials), "Placebo" (2 trials), "anastrozole" (2 trials), "bevacizumab" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Middlesex Hospital Cancer Center" are 11 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Middlesex Hospital Cancer Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Middlesex Hospital Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Middlesex Hospital Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".